3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Prostatic Neoplasms
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Sleep Apnea Syndromes
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lung Neoplasms
1
Hypertension
1
Hyperlipidemias
1
Gastroesophageal Reflux
1
Eczema
1
Disease
1
Digestive System Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Dermatitis, Atopic
1
Collagen Diseases
1
Adenocarcinoma
1
Interventions
pembrolizumab
69
Nivolumab
67
cabozantinib
45
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
32
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
17
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Urine Specimen Collection
×
1 year
×
Clear all
No trials found.